Effect of Topical Administration of Somatostatin on Retinal Inflammation and Neurodegeneration in an Experimental Model of Diabetes
Somatostatin (SST) is a neuroprotective peptide but little is known regarding the potential role of its anti-inflammatory effects on retinal neuroprotection. In a previous study, we provided the first evidence that topical (eye drops) administration of SST prevents retinal neurodegeneration in strep...
Main Authors: | Cristina Hernández, Ana I Arroba, Patricia Bogdanov, Hugo Ramos, Olga Simó-Servat, Rafael Simó, Angela M Valverde |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-08-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/9/8/2579 |
Similar Items
-
Topical Administration of Bosentan Prevents Retinal Neurodegeneration in Experimental Diabetes
by: Patricia Bogdanov, et al.
Published: (2018-11-01) -
Effects of Liposomal Formulation of Citicoline in Experimental Diabetes-Induced Retinal Neurodegeneration
by: Patricia Bogdanov, et al.
Published: (2018-08-01) -
Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes
by: Rafael Simó, et al.
Published: (2021-07-01) -
The Herbal Combination CPA4-1 Inhibits Changes in Retinal Capillaries and Reduction of Retinal Occludin in db/db Mice
by: Young Sook Kim, et al.
Published: (2020-07-01) -
Eucalyptol Inhibits Amyloid-β-Induced Barrier Dysfunction in Glucose-Exposed Retinal Pigment Epithelial Cells and Diabetic Eyes
by: Dong Yeon Kim, et al.
Published: (2020-10-01)